Skip to content

CCCC - C4 Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

C4 Therapeutics Inc

CCCC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CCCCC4 Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $5.17
52-wk low: $1.69
Prev close: $3.25
Mkt cap: $514.2M
Beta: 2.95
P/S: 14.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$129.3M

CI
Citadel
Ken Griffin · Q2 2026 13F
$19.6M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 21.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -289.4%
Market cap: $514M

Valuation

P/S14.68
P/B2.12

Quality

Operating margin-397.9%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CCCC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $514.25M
Beta: 2.95

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.1x

Profit margin

-289.4%

Op margin

-397.9%

ROE

-48.1%

$16.2M

position

DS

D.E. Shaw

Q2 2026 13F

$8.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CCCC

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.18+21.7%

-$0.23 expected

Next report

What the street expects next

-48.1%

ROA-19.3%

Growth

Beta2.95